CycLuc1

CAS No. 1247879-16-8

CycLuc1( —— )

Catalog No. M26659 CAS No. 1247879-16-8

CycLuc1 is a brain penetrant luciferase substrate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 Get Quote
10MG 58 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CycLuc1
  • Note
    Research use only, not for human use.
  • Brief Description
    CycLuc1 is a brain penetrant luciferase substrate.
  • Description
    CycLuc1 is a brain penetrant luciferase substrate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    P-selectin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1247879-16-8
  • Formula Weight
    305.37
  • Molecular Formula
    C13H11N3O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 83.33 mg/mL (272.87 )
  • SMILES
    OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.S Ohta, et al. Inhibition of P-selectin specific cell adhesion by a low molecular weight, non-carbohydrate compound, KF38789. Inflamm Res. 2001 Nov;50(11):544-51.
molnova catalog
related products
  • Spinosad

    Spinosad is a naturally-occurring insecticide found in the the soil bacterium S. spinosa.?

  • FEN1 Inhibitor C2

    FEN1-IN-4 is an inhibitor of human flap endonuclease-1 (hFEN1)FEN1 Inhibitor C2 inhibition selectively impairs proliferation of colon cancer cells deficient in Cdc4 and Mre11a, both frequently mutated in colorectal cancers.?

  • Mitazalimab

    Mitazalimab (ADC-1013; JNJ-64457107) is an FcγR-dependent CD40 agonist that targets tumors by activating antigen-presenting cells like dendritic cells (DC), initiating tumor-reactive T cells, promoting tumor-specific T cell infiltration and destruction of tumors, and remodeling the tumor-infiltrating myeloid microenvironment .